Creating Patient-Specific Neural Cells for the in Vitro Study of Brain Disorders

Kristen J. Brennand, M. Carol Marchetto, Nissim Benvenisty, Oliver Brüstle, Allison Ebert, Juan Carlos Izpisua Belmonte, Ajamete Kaykas, Madeline A. Lancaster, Frederick J. Livesey, Michael J. McConnell, Ronald D. McKay, Eric M. Morrow, Alysson R. Muotri, David M. Panchision, Lee L. Rubin, Akira Sawa, Frank Soldner, Hongjun Song, Lorenz Studer, Sally TempleFlora M. Vaccarino, Jun Wu, Pierre Vanderhaeghen, Fred H. Gage*, Rudolf Jaenisch

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

66 Scopus citations


As a group, we met to discuss the current challenges for creating meaningful patient-specific in vitro models to study brain disorders. Although the convergence of findings between laboratories and patient cohorts provided us confidence and optimism that hiPSC-based platforms will inform future drug discovery efforts, a number of critical technical challenges remain. This opinion piece outlines our collective views on the current state of hiPSC-based disease modeling and discusses what we see to be the critical objectives that must be addressed collectively as a field.

Original languageAmerican English
Pages (from-to)933-945
Number of pages13
JournalStem Cell Reports
Issue number6
StatePublished - 8 Dec 2015

Bibliographical note

Publisher Copyright:
© 2015 The Authors.


Dive into the research topics of 'Creating Patient-Specific Neural Cells for the in Vitro Study of Brain Disorders'. Together they form a unique fingerprint.

Cite this